IRIS Accounts Production v26.2.0.496 12727107 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false false true false Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh127271072025-03-31127271072026-03-31127271072025-04-012026-03-31127271072024-03-31127271072024-04-012025-03-31127271072025-03-3112727107ns15:EnglandWales2025-04-012026-03-3112727107ns14:PoundSterling2025-04-012026-03-3112727107ns10:Director12025-04-012026-03-3112727107ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3112727107ns10:SmallEntities2025-04-012026-03-3112727107ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3112727107ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3112727107ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3112727107ns10:FullAccounts2025-04-012026-03-311272710712025-04-012026-03-3112727107ns10:OrdinaryShareClass12025-04-012026-03-3112727107ns10:Director22025-04-012026-03-3112727107ns10:RegisteredOffice2025-04-012026-03-3112727107ns5:CurrentFinancialInstruments2026-03-3112727107ns5:CurrentFinancialInstruments2025-03-3112727107ns5:Non-currentFinancialInstruments2026-03-3112727107ns5:Non-currentFinancialInstruments2025-03-3112727107ns5:ShareCapital2026-03-3112727107ns5:ShareCapital2025-03-3112727107ns5:RetainedEarningsAccumulatedLosses2026-03-3112727107ns5:RetainedEarningsAccumulatedLosses2025-03-3112727107ns5:NetGoodwill2025-04-012026-03-3112727107ns5:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3112727107ns5:FurnitureFittings2025-04-012026-03-3112727107ns5:MotorVehicles2025-04-012026-03-3112727107ns5:NetGoodwill2025-03-3112727107ns5:NetGoodwill2026-03-3112727107ns5:NetGoodwill2025-03-3112727107ns5:FurnitureFittings2025-03-3112727107ns5:MotorVehicles2025-03-3112727107ns5:FurnitureFittings2026-03-3112727107ns5:MotorVehicles2026-03-3112727107ns5:FurnitureFittings2025-03-3112727107ns5:MotorVehicles2025-03-3112727107ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3112727107ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3112727107ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2026-03-3112727107ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-03-3112727107ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2026-03-3112727107ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3112727107ns5:DeferredTaxation2025-03-3112727107ns5:DeferredTaxation2025-04-012026-03-3112727107ns5:DeferredTaxation2026-03-3112727107ns10:OrdinaryShareClass12026-03-3112727107ns5:RetainedEarningsAccumulatedLosses2025-03-3112727107ns5:RetainedEarningsAccumulatedLosses2025-04-012026-03-31
REGISTERED NUMBER: 12727107 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2026

for

CHURCH PHARMA (BILSTON) LTD

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHURCH PHARMA (BILSTON) LTD

Company Information
for the Year Ended 31 March 2026







DIRECTORS: Mohan Lal Sahni
Jaswinder Paul Sahni





REGISTERED OFFICE: 43A - 45 Church St
Bilston
United Kingdom
WV14 0AX





REGISTERED NUMBER: 12727107 (England and Wales)





ACCOUNTANTS: Brindleys Limited
2 Wheeleys Road
Edgbaston
Birmingham
West Midlands
B15 2LD

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Balance Sheet
31 March 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 603,273 643,491
Tangible assets 5 49,683 51,426
652,956 694,917

CURRENT ASSETS
Stocks 6 112,000 87,000
Debtors 7 661,438 763,719
Cash at bank and in hand 50,263 66,565
823,701 917,284
CREDITORS
Amounts falling due within one year 8 1,143,759 1,284,202
NET CURRENT LIABILITIES (320,058 ) (366,918 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

332,898

327,999

CREDITORS
Amounts falling due after more than one year 9 (48,992 ) (92,070 )

PROVISIONS FOR LIABILITIES 11 (12,421 ) (12,856 )
NET ASSETS 271,485 223,073

CAPITAL AND RESERVES
Called up share capital 12 1 1
Retained earnings 13 271,484 223,072
SHAREHOLDERS' FUNDS 271,485 223,073

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Balance Sheet - continued
31 March 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 August 2026 and were signed on its behalf by:





Mohan Lal Sahni - Director


CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Church Pharma (Bilston) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2025 - 20 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2025
and 31 March 2026 804,364
AMORTISATION
At 1 April 2025 160,873
Charge for year 40,218
At 31 March 2026 201,091
NET BOOK VALUE
At 31 March 2026 603,273
At 31 March 2025 643,491

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 April 2025 95,534 1,581 97,115
Additions 7,084 - 7,084
At 31 March 2026 102,618 1,581 104,199
DEPRECIATION
At 1 April 2025 44,608 1,081 45,689
Charge for year 8,702 125 8,827
At 31 March 2026 53,310 1,206 54,516
NET BOOK VALUE
At 31 March 2026 49,308 375 49,683
At 31 March 2025 50,926 500 51,426

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

6. STOCKS
2026 2025
£    £   
Stocks 112,000 87,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 157,668 132,665
Amounts owed by group undertakings 450,066 472,889
Other debtors 23,236 130,000
VAT 20,592 19,034
Prepayments 9,876 9,131
661,438 763,719

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Bank loans and overdrafts (see note 10) 40,422 34,764
Trade creditors 194,338 224,647
Amounts owed to group undertakings 864,887 912,146
Tax 29,979 43,349
Social security and other taxes 3,609 3,141
Other creditors 615 58,629
Accrued expenses 9,909 7,526
1,143,759 1,284,202

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2026 2025
£    £   
Bank loans (see note 10) 48,992 92,070

10. LOANS

An analysis of the maturity of loans is given below:

2026 2025
£    £   
Amounts falling due within one year or on demand:
Bank loans 40,422 34,764

Amounts falling due between one and two years:
Bank loans - 1-2 years 40,422 34,764

CHURCH PHARMA (BILSTON) LTD (REGISTERED NUMBER: 12727107)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

10. LOANS - continued
2026 2025
£    £   
Amounts falling due between two and five years:
Bank loans - 2-5 years 8,570 57,306

11. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 12,421 12,856

Deferred
tax
£   
Balance at 1 April 2025 12,856
Provided during year (435 )
Balance at 31 March 2026 12,421

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
1 Ordinary A 1 1 1

13. RESERVES
Retained
earnings
£   

At 1 April 2025 223,072
Profit for the year 48,412
At 31 March 2026 271,484